World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
30299
World Ranking
17853
National Ranking
8909

Overview

Marc G. Ghany is affiliated with the National Institutes of Health in the United States. Their work primarily spans the field of Medicine with a focus on several key subfields including Epidemiology, Hepatology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging, and Immunology.

The scientist's research focuses on important topics related to liver and infectious diseases. These topics include Hepatitis B Virus Studies, Hepatitis C Virus Research, Liver Disease Diagnosis and Treatment, Hepatitis Viruses Studies and Epidemiology, Liver Disease and Transplantation, HIV/AIDS Drug Development and Treatment, and SARS-CoV-2 and COVID-19 Research.

Marc G. Ghany's recent publications cover significant aspects of viral hepatitis and liver disease as well as implications for clinical care during the COVID-19 pandemic. Selected papers include:

  • Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection, 2021, New England Journal of Medicine
  • Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad, 2020, The Lancet Gastroenterology & Hepatology
  • Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care, 2020, Hepatology
  • Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference, 2023, Hepatology
  • Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference, 2023, Journal of Hepatology

The scientist has frequently published in high-impact journals, with multiple papers appearing in:

  • Hepatology
  • Gastroenterology
  • The American Journal of Gastroenterology
  • Alimentary Pharmacology & Therapeutics
  • Journal of Hepatology

Research collaborations are evident through frequent co-authors including Richard K. Sterling, Mandana Khalili, Wendy C. King, Mauricio Lisker-Melman, and David E. Kleiner, each contributing in multiple joint studies.

Best Publications

  • Diagnosis, management, and treatment of hepatitis C: An update

    Marc G. Ghany;Doris B. Strader;David L. Thomas;Leonard B. Seeff

  • An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

    Marc G. Ghany;David R. Nelson;Doris B. Strader;David L. Thomas

  • A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.

    Kittichai Promrat;Glen Lutchman;Gabriel I. Uwaifo;Renee J. Freedman

  • Hepatitis B cure: From discovery to regulatory approval

    Anna S. Lok;Fabien Zoulim;Geoffrey Dusheiko;Marc G. Ghany

  • Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

    Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks

  • Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Marc G Ghany;Timothy R Morgan

  • Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

    Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz

  • Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

    Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima

  • Current and future therapies for hepatitis C virus infection.

    T. Jake Liang;Marc G. Ghany

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C

    Timothy R. Morgan;Timothy R. Morgan;Marc G. Ghany;Hae Young Kim;Kristin K. Snow

  • Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

    Adrian M. Di Bisceglie;Mitchell L. Shiffman;Gregory T. Everson;Karen L. Lindsay

  • Long‐term therapy of chronic hepatitis B with lamivudine

    Daryl T.-Y. Lau;M. Farooq Khokhar;Edward Doo;Marc G. Ghany

  • Progression of fibrosis in chronic hepatitis C

    Marc G. Ghany;David E. Kleiner;Harvey Alter;Edward Doo

  • Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

    Leonard B. Seeff;Gregory T. Everson;Timothy R. Morgan;Teresa M. Curto

  • Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial☆

    Adrian M. Di Bisceglie;Richard K. Sterling;Raymond T. Chung;James E. Everhart

  • Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT‐C cohort

    Anna S F Lok;Marc G. Ghany;Zachary D. Goodman;Elizabeth C. Wright

  • Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

    Marc G. Ghany;Brick Ayola;Federico G. Villamil;Robert G. Gish

  • Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy

    Jasmohan S. Bajaj;Jasmohan S. Bajaj;Christine M. Schubert;Douglas M. Heuman;James B. Wade

  • Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort Potential conflict of interest: Nothing to report.

    Anna Suk-Fong Lok;Marc G. Ghany;Zachary D. Goodman;Elizabeth C. Wright

Frequent Co-Authors

T. Jake Liang
T. Jake Liang National Institutes of Health
David E. Kleiner
David E. Kleiner National Institutes of Health
Jay H. Hoofnagle
Jay H. Hoofnagle National Institutes of Health
Timothy R. Morgan
Timothy R. Morgan California State University, Long Beach
Herbert L. Bonkovsky
Herbert L. Bonkovsky Wake Forest University
Adrian M. Di Bisceglie
Adrian M. Di Bisceglie Saint Louis University
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Theo Heller
Theo Heller National Institutes of Health
Richard K. Sterling
Richard K. Sterling Virginia Commonwealth University
Jules L. Dienstag
Jules L. Dienstag Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Planning for a career in Medicine often involves exploring a wide range of related healthcare fields. Many students and professionals are now turning to flexible online programs to gain specialized credentials and advance their careers. Whether you’re interested in becoming a pharmacist or working in healthcare support roles, there are diverse educational opportunities available online.

For those considering a pharmacy path, earning a pharmacy degree online can open doors to clinical and leadership positions within the pharmaceutical industry. Others may be drawn to the administrative side of healthcare, where rhit programs online offer training in managing critical patient data and health records.

Students interested in billing and coding can pursue medical billing and coding certification online to gain skills for entry-level positions in this high-demand area. For those aiming to advance in patient care, affordable online fnp programs provide a pathway to become a family nurse practitioner, combining clinical practice and flexibility.

Best Scientists Citing Marc G. Ghany

Trending Scientists

Recently Published Articles